Better Therapeutics’ $187 Million Merger Agreement with Mountain Crest Acquisition Corp II

Goodwin Procter LLP advised Better Therapeutics, Inc. on the deal.Better Therapeutics, Inc. announced its definitive merger agreement with Mountain Crest Acquisition Corp II (Nasdaq: MCAD;), a publicly…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here